SA
MLAB icon

Sanctuary Advisors’s Mesa Laboratories MLAB Stock Holding History

Sanctuary Advisors’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,107
Closed -$217K – 2599
2024
Q2 		$217K Buy
+2,107
New +$221K ﹤0.01% 2138

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanctuary Advisors's MLAB Position: Q3 2024 in Review

Sanctuary Advisors sold out of Mesa Laboratories (MLAB) in Q3 2024, closing a stake of 2,107 shares — an estimated $217K sold.

Sanctuary Advisors first reported a position in MLAB in Q2 2024 and held it in 1 quarter. The position peaked at $217K in Q2 2024. 166 funds tracked by Wall St. Rank hold MLAB as of Q3 2024.

  • Sanctuary Advisors reported no remaining Mesa Laboratories position as of Q3 2024 after selling out during the quarter.
  • Sanctuary Advisors sold 2,107 Mesa Laboratories shares in Q3 2024, an estimated $217K.
  • Sanctuary Advisors first reported a position in Mesa Laboratories in Q2 2024 and held it in 1 quarter.
  • Sanctuary Advisors's Mesa Laboratories position peaked at $217K in Q2 2024.
  • 166 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2024.

Based on Sanctuary Advisors's 13F filing for Q3 2024, filed 25 Nov 2024.